Tanager Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,031
Closed -$316K 159
2026
Q1
$316K Buy
5,031
+97
+2% +$7.76K 0.03% 111
2025
Q4
$470K Sell
4,934
-44
-0.9% -$4.31K 0.05% 84
2025
Q3
$486K Buy
4,978
+318
+7% +$32.9K 0.05% 76
2025
Q2
$501K Buy
4,660
+59
+1% +$5.97K 0.06% 76
2025
Q1
$464K Buy
4,601
+737
+19% +$74.2K 0.06% 72
2024
Q4
$345K Buy
3,864
+244
+7% +$21.5K 0.04% 78
2024
Q3
$303K Buy
3,620
+492
+16% +$38.8K 0.04% 84
2024
Q2
$241K Buy
3,128
+15
+0.5% +$1.1K 0.04% 83
2024
Q1
$213K Buy
+3,113
New +$200K 0.03% 84
2023
Q1
Sell
-4,461
Closed -$206K 73
2022
Q4
$206K Buy
+4,461
New +$193K 0.06% 73

Other funds holding BSX

Tanager Wealth Management's BSX Position: Q2 2026 in Review

Tanager Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 5,031 shares — an estimated $316K sold.

Tanager Wealth Management first reported a position in BSX in Q4 2022 and held it in 10 quarters. The position peaked at $501K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Tanager Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Tanager Wealth Management sold 5,031 Boston Scientific shares in Q2 2026, an estimated $316K.
  • Tanager Wealth Management first reported a position in Boston Scientific in Q4 2022 and held it in 10 quarters.
  • Tanager Wealth Management's Boston Scientific position peaked at $501K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Tanager Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.